Skip to main content
Premium Trial:

Request an Annual Quote

Beijing Proteomics Lab Licenses GeneBio's Phenyx

NEW YORK (GenomeWeb News) – The Chinese State Key Laboratory of Proteomics has licensed Geneva Bioinformatics’ protein identification platform for use in its research efforts, GeneBio said today.
 
Under the agreement, the Beijing-based institute will use the Phenyx software, which GeneBio developed through a collaboration with the Swiss Institute of Bioinformatics, in various proteomics research projects led by Fuchu He, who is co-chair of the Human Proteome Organization’s Human Liver Proteome Project.
 
The Phenyx software is used to identify and characterize proteins and peptides from mass spectrometry data.
 
Financial terms of the agreement were not released.
 
The Key Lab’s research projects include studies of disease, systems biology, and novel proteomics investigations, and it conducts various proteomics efforts involving protein expression, modification, bioinformatics, localization, functional genomics, and protein engineering.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.